|
|
|
LifeScienceHistory.com - Check us out on Instagram
Take Your Next Career Step with Lundback
Minnesota Life Science Industry Directory
Banner Advertising
Please note that we have a new site: LifeScienceHistory.com, "Where history is made daily" under development and
delayed by COVID-19, to be launched in 2023 replacing MinnesotaLifeScience.com. Regrettably, we are working with reduced
staffing and the current industry directory is no longer being maintained, but will be replaced with a new and improved
directory upon the launch of the new site. We apologize for the inconvenience.
Tendyne Holdings, Inc.
| | | Phone: | (651) 289-5500 | Fax: | (651) 289-5501 | Year Established: | 2010 | Ticker: | ABT | Exchange: | NYSE | Main Contact: | Jeff Franco, CEO | | Other Contacts: | Erik Kari, Senior Director of Quality Bob Vidlund, VP, R&D Dan Mans, VP, Clinical and Therapy Development
| | Company Description | Tendyne Holdings, an Abbott company, is a clinical stage medical device company focused on the development of minimally invasive therapies for the treatment of mitral regurgitation. Mitral regurgitation is a condition that afflicts hundreds of thousands of individuals worldwide every year. | |
|
|
|
|
|